ACC.23/WCC Clinical Trials Recap
Listen to concise summaries from FITs from the University of Michigan, with commentary from ACC.org Editor-in-Chief Kim A. Eagle, MD, MACC, on the most impactful late-breaking clinical trials from ACC.23/WCC. Trials include CLEAR Outcomes, Oral PCSK9 Inhibitor MK-0616, STELLAR, PULSED-AF, RAPID-HF, FREEDOM-COVID, TRILUMINATE Pivotal, LIVE-HCM, Return to Play, BETTER CARE HF, COAPT 5-Year Follow Up, STOP-CA and Wrist-Worn Transdermal TnI Sensor.
Would you like to see these sessions in their entirety? Purchase the ALL-NEW ACC Anywhere and get 1 year of access to a comprehensive library of all of ACC's in-person and virtual courses – including 200+ sessions from ACC.23/WCC. Plus, earn up to 100 credits per calendar year. Reminder: a 1-year subscription is included with your ACC.23/WCC registration. Claim your credit or certificate of attendance from ACC.23/WCC by Wednesday, June 7.